Need help choosing the right code?
Ask CasePilot about procedures, modifiers, bundling, and coding guidance.
Try CasePilot© Copyright 2026 American Medical Association. All rights reserved.
Tetanus toxoid adsorbed, for intramuscular use, is a vaccine designed to provide long-lasting immunity against the toxin produced by the bacterium Clostridium tetani. This vaccine works by stimulating the body's immune system to produce antibodies that specifically target and neutralize the tetanus toxin. The process of creating the toxoid involves culturing the bacteria in a controlled liquid medium, followed by purification and inactivation of the toxin, rendering it non-infectious while still capable of eliciting an immune response. As a result, the vaccine is classified as a toxoid rather than a live vaccine. It is important to note that immunity from the tetanus toxoid can diminish over time, which is why booster doses are recommended to maintain adequate protection. The administration of this vaccine is performed via intramuscular injection, ensuring that it is delivered effectively into the muscle tissue. This code, CPT® 90703, specifically reports the use of tetanus toxoid alone, distinguishing it from other related vaccines, such as diphtheria and tetanus toxoids (DT) adsorbed, which is reported under CPT® code 90702 for patients younger than 7 years. Both codes serve to identify the specific toxoid product utilized in immunization efforts.
© Copyright 2026 Coding Ahead. All rights reserved.
The tetanus toxoid vaccine is indicated for the prevention of tetanus, a serious bacterial infection caused by the toxin produced by Clostridium tetani. The following conditions warrant the administration of this vaccine:
The procedure for administering the tetanus toxoid vaccine involves several key steps to ensure safety and efficacy:
Following the administration of the tetanus toxoid vaccine, patients are typically advised to remain in the healthcare setting for a short period to monitor for any immediate allergic reactions. Common post-procedure care includes advising patients to apply a cool compress to the injection site to alleviate any discomfort or swelling. Patients may experience mild side effects such as soreness at the injection site, low-grade fever, or fatigue, which usually resolve within a few days. It is important for patients to keep track of their vaccination history and schedule any necessary booster doses as recommended by healthcare guidelines to ensure continued immunity against tetanus.
| Short Descr | TETANUS VACCINE IM | Medium Descr | TETANUS TOXOID ADSORBED INTRAMUSCULAR | Long Descr | Tetanus toxoid adsorbed, for intramuscular use | Related Drugs | TETANUS TOXOID ABSORBED INJECTION | Status Code | Excluded from Physician Fee Schedule by Regulation | Global Days | XXX - Global Concept Does Not Apply | PC/TC Indicator (26, TC) | 9 - Not Applicable | Multiple Procedures (51) | 9 - Concept does not apply. | Bilateral Surgery (50) | 9 - Concept does not apply. | Physician Supervisions | 09 - Concept does not apply. | Assistant Surgeon (80, 82) | 9 - Concept does not apply. | Co-Surgeons (62) | 9 - Concept does not apply. | Team Surgery (66) | 9 - Concept does not apply. | Diagnostic Imaging Family | 99 - Concept Does Not Apply | APC Status Indicator | Items and Services Packaged into APC Rates | Type of Service (TOS) | 1 - Medical Care | Berenson-Eggers TOS (BETOS) | O1G - Immunizations/Vaccinations | MUE | Not applicable/unspecified. | CCS Clinical Classification | 228 - Prophylactic vaccinations and inoculations |
|
Date
|
Action
|
Notes
|
|---|---|---|
| 2016-01-01 | Deleted | Deleted |
| 2011-01-01 | Changed | Short description changed. |
| 2004-01-01 | Changed | Code description changed. |
| Pre-1990 | Added | Code added. |
Get instant expert-level medical coding assistance.